INJECTIONS • INJECTIONS

HEPRIO 25000

Heprin 25000IU Injection

Schedule H Prescription Drug
Printed MRP: ₹320.25 (Incl. of all taxes)
★ PCD Franchise Offer: Attractive Margins
Packaging Form
5 mi Vial
Standard Specification
IP / BP / USP Pharmacopoeial Standards
Brand Family
HEPRIO 25000 Series
Franchise Territory
District Monopoly Available
Order / Pay Online

Product Technical Snapshot

Official pharmaceutical registration and manufacturing parameters

Brand Name HEPRIO 25000
Active Formulation (Salt) Heprin 25000IU Injection
Dosage Form INJECTIONS
Packaging Presentation 5 mi Vial
Therapeutic Category INJECTIONS
Regulatory Classification Schedule H Prescription Drug
Pharmacopoeial Standard IP / BP / USP Pharmacopoeial Standards
Quality Certifications WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
Marketed & Distributed By Riomedica Healthcare Pvt. Ltd. (Ambala Cantt & Panchkula, Haryana)
B2B Franchise Availability Monopoly PCD Franchise rights available across all Indian districts

What is HEPRIO 25000?

Therapeutic monograph and clinical profile

HEPRIO 25000 (Heprin 25000IU Injection) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 5 mi Vial, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Deep Vein Thrombosis (DVT) / Pulmonary Embolism (PE).

Key Formulation Highlights

Why healthcare professionals recommend HEPRIO 25000

WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
DCGI Approved Formulation with Proven Chemical Purity
High Bioavailability & Predictable Pharmacokinetics
Premium Moisture-Proof Protective Packaging
Exclusive Monopoly PCD Pharma Franchise Rights Available

Therapeutic Uses & Clinical Indications

Conditions and clinical disorders managed by this medicine

Recommended Clinical Indications:

Deep Vein Thrombosis (DVT) / Pulmonary Embolism (PE)

Pharmacological Mechanism of Action

How HEPRIO 25000 acts biochemically in the body

Delivers targeted active therapeutic release with rapid absorption and high safety profile.

Dosage & Administration Guidance

Proper usage directions under clinical supervision

As directed by the physician or healthcare professional. Take with water at prescribed intervals.

Precautions, Warnings & Contraindications

Safety guidelines and patient health considerations

Clinical Safety & Medical Advice:

Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.

Possible Side Effects

Tolerability profile and reporting

Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.

Storage & Handling Instructions

Maintaining formulation stability and shelf-life

Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.

Exclusive PCD Pharma Franchise Opportunity for HEPRIO 25000

Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for HEPRIO 25000 across India with comprehensive visual aids, prompt dispatch, and high profit margins.

Frequently Asked Questions (FAQs)

Common queries regarding HEPRIO 25000

What is HEPRIO 25000 used for?
HEPRIO 25000 is prescribed for Deep Vein Thrombosis (DVT) / Pulmonary Embolism (PE). Always follow physician dosage instructions.
What is the printed packaging and MRP of HEPRIO 25000?
The printed packaging is 5 mi Vial with an MRP of ₹320.25.
How can I get monopoly PCD franchise for HEPRIO 25000?
You can request district monopoly rights directly via sales@riomedicahealthcare.com or WhatsApp +91 82229 99973.
×

PCD Franchise Enquiry

Get monopoly rights, wholesale price list & free promotional visual aids.